{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:44:42Z","timestamp":1785300282783,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","award":["12866"],"award-info":[{"award-number":["12866"]}],"id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.humpath.2022.08.002","type":"journal-article","created":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T01:19:42Z","timestamp":1661044782000},"page":"40-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Alpha-methylacyl-CoA racemase (AMACR) protein is upregulated in early proliferative lesions of the breast irrespective of apocrine differentiation"],"prefix":"10.1016","volume":"129","author":[{"given":"Zoran","family":"Gatalica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semir","family":"Vranic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.08.002_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3945\/ajcn.116.132464","article-title":"Branched-chain fatty acid composition of human milk and the impact of maternal diet: the Global Exploration of Human Milk (GEHM) Study","volume":"105","author":"Dingess","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.humpath.2022.08.002_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fmolb.2020.00153","article-title":"Current knowledge on the function of alpha-methyl Acyl-CoA racemase in human diseases","volume":"7","author":"Kong","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.humpath.2022.08.002_bib3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1742-4658.2008.06290.x","article-title":"Alpha-methylacyl-CoA racemase--an 'obscure' metabolic enzyme takes centre stage","volume":"275","author":"Lloyd","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.humpath.2022.08.002_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/hmg\/ddh107","article-title":"A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids","volume":"13","author":"Savolainen","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.humpath.2022.08.002_bib5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0046-8177(03)00268-5","article-title":"Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases","volume":"34","author":"Jiang","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.08.002_bib6","first-page":"2220","article-title":"Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer","volume":"62","author":"Luo","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2022.08.002_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/modpathol.3800520","article-title":"Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma","volume":"19","author":"Olgac","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.08.002_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00129039-200509000-00007","article-title":"Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer","volume":"13","author":"Nassar","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2022.08.002_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00000478-200401000-00007","article-title":"Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma","volume":"28","author":"Tretiakova","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.08.002_bib10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00000478-200207000-00012","article-title":"Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions","volume":"26","author":"Zhou","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.08.002_bib11","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/1055-9965.EPI-04-0607","article-title":"Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis","volume":"14","author":"Witkiewicz","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.humpath.2022.08.002_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.humpath.2021.07.005","article-title":"alpha-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiation","volume":"116","author":"Nakamura","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.08.002_bib13","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2022.08.002_bib14","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update","volume":"142","author":"Wolff","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2022.08.002_bib15","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St gallen international expert Consensus on the primary therapy of early breast cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2022.08.002_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.08.002_bib17","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2022.08.002_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.humpath.2022.08.002_bib19","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat Protoc"},{"key":"10.1016\/j.humpath.2022.08.002_bib20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/00000478-200111000-00007","article-title":"P504S: a new molecular marker for the detection of prostate carcinoma","volume":"25","author":"Jiang","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.08.002_bib21","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0022-2275(20)31983-0","article-title":"Subcellular localization and physiological role of alpha-methylacyl-CoA racemase","volume":"41","author":"Ferdinandusse","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.humpath.2022.08.002_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071692","article-title":"Peroxisome metabolism in cancer","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.humpath.2022.08.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.30683\/1929-2279.2019.08.01","article-title":"HER2 expression discordance between ductal carcinoma in situ and invasive breast carcinoma. How to analyze oncotype DX","volume":"8","author":"Irene","year":"2019","journal-title":"J Cancer Res Updates"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:40:13Z","timestamp":1758645613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722002118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":23,"alternative-id":["S0046817722002118"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.08.002","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-methylacyl-CoA racemase (AMACR) protein is upregulated in early proliferative lesions of the breast irrespective of apocrine differentiation","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}